NATURE’S SUNSHINE PRODUCTS, INC. Unrecognized Tax Benefits
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) had Unrecognized Tax Benefits of $100.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefits · last filed 2026-08-06
- 2026-06-30: Unrecognized Tax Benefits $100.00K.
- 2026-03-31: Unrecognized Tax Benefits $500.00K.
- 2025-12-31: Unrecognized Tax Benefits $400.00K.
- 2025-09-30: Unrecognized Tax Benefits $500.00K.
| Period end | Unrecognized Tax Benefits | Unrecognized Tax Benefits as first filed |
|---|---|---|
| 2026-06-30 | $100.00K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $500.00K 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $400.00K 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $500.00K 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $600.00K 10-Q · filed 2025-07-31 | |
| 2025-03-31 | $600.00K 10-Q · filed 2025-05-06 | |
| 2024-12-31 | $600.00K 10-Q · filed 2025-11-06 | $300.00K 10-K · filed 2025-03-11 |
| 2024-09-30 | $700.00K 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $900.00K 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $600.00K 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $400.00K 10-K · filed 2025-03-11 | |
| 2023-09-30 | $200.00K 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $200.00K 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $200.00K 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $200.00K 10-K · filed 2024-03-12 | $209.00K 10-K · filed 2023-03-16 |
| 2022-09-30 | $200.00K 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $0.00 10-K · filed 2023-03-16 | |
| 2021-09-30 | $5.00K 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $5.00K 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $100.00K 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $92.00K 10-K · filed 2022-03-08 | |
| 2020-09-30 | $100.00K 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $1.40M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $1.40M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $1.50M 10-K · filed 2021-03-10 | |
| 2019-09-30 | $1.50M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $2.20M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $2.13M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $2.19M 10-K · filed 2020-03-11 | |
| 2018-09-30 | $2.20M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $4.80M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $4.71M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $4.63M 10-K · filed 2019-03-08 | |
| 2017-09-30 | $4.90M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $6.97M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $6.82M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $6.75M 10-K · filed 2018-03-16 | |
| 2016-09-30 | $6.09M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $7.81M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $7.78M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $7.81M 10-K · filed 2017-03-14 | |
| 2015-09-30 | $6.98M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $7.06M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $6.78M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $6.60M 10-K · filed 2016-03-14 | |
| 2014-09-30 | $8.85M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $13.22M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $12.35M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $12.40M 10-K · filed 2015-03-13 | |
| 2013-09-30 | $11.49M 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $10.80M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $10.61M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $10.57M 10-K · filed 2014-03-17 | |
| 2012-09-30 | $9.77M 10-Q · filed 2012-11-06 | |
| 2012-06-30 | $9.78M 10-Q · filed 2012-08-03 | |
| 2012-03-31 | $9.16M 10-Q · filed 2012-05-08 | |
| 2011-12-31 | $10.43M 10-K · filed 2013-03-07 | |
| 2011-09-30 | $18.56M 10-Q · filed 2011-11-08 | |
| 2011-06-30 | $20.86M 10-Q · filed 2011-08-05 | |
| 2010-12-31 | $21.37M 10-K · filed 2012-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |